|
VAV3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13579999960756E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.16040000053275E-07 |
| Normal-vs-Stage2 |
1.195370E-03 |
| Normal-vs-Stage3 |
1.003610E-01 |
| Normal-vs-Stage4 |
7.724100E-02 |
| Stage1-vs-Stage2 |
2.856600E-01 |
| Stage1-vs-Stage3 |
1.232000E-02 |
| Stage1-vs-Stage4 |
3.812800E-01 |
| Stage2-vs-Stage3 |
2.256200E-02 |
| Stage2-vs-Stage4 |
1.700970E-01 |
| Stage3-vs-Stage4 |
4.696800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.698550E-03 |
| Normal-vs-AfricanAmerican |
1.628040E-02 |
| Normal-vs-Asian |
2.117900E-03 |
| Caucasian-vs-AfricanAmerican |
9.775600E-02 |
| Caucasian-vs-Asian |
4.151800E-02 |
| AfricanAmerican-vs-Asian |
5.670400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.842780E-04 |
| Normal-vs-Female |
1.289399999993E-06 |
| Male-vs-Female |
7.294000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.87268999999324E-05 |
| Normal-vs-Age(41-60Yrs) |
2.156600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.177900E-03 |
| Normal-vs-Age(81-100Yrs) |
8.198400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.192800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.422200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.454200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.288600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.649800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.674000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.76560000000525E-05 |
| Classical-VS-Follicular |
1.37119982035472E-10 |
| Classical-VS-Other |
7.446200E-01 |
| Classical-VS-Normal |
4.023600E-03 |
| Tall-VS-Follicular |
8.88178419700125E-16 |
| Tall-VS-Other |
1.267160E-01 |
| Tall-VS-Normal |
7.784300E-02 |
| Follicular-VS-Other |
3.646500E-04 |
| Follicular-VS-Normal |
5.57331958361829E-14 |
| Other-VS-Normal |
4.923800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12770000004758E-08 |
| Normal-vs-N1 |
2.695700E-02 |
| N0-vs-N1 |
2.837200E-01 |
|
|
